Picco, Vincent
Research Associate
Centre Scientifique de Monaco, Principality of Monaco
Targeted therapies
We study the capacity of certain anti-angiogenic targeted therapies to permeabilize and pass the BBB.
Existing collaborations relevant to drug delivery
J. Gavard Centre de Recherche en Cancérologie Immunologie Nantes-Angers CRCINA, CNRS ERL 6001, INSERM U1232 Université de Nantes
Publications relevant to drug delivery
Pagnuzzi-Boncompagni M, Picco V, Vial V, Planas-Bielsa V, Vandenberghe A, Grépin R, Durivault J, Montemagno C, Martial S, Doyen J, Gavard J, Pagès G. The anti-angiogenic compound axitinib demonstrates low toxicity and anti-tumoral effects against medulloblastoma. doi: https://doi.org/10.1101/2020.09.18.301028
Email for contact details